Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 8.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,687,346 shares of the medical equipment provider's stock after selling 152,189 shares during the period. Ameriprise Financial Inc. owned approximately 0.47% of Intuitive Surgical worth $880,832,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the 4th quarter valued at about $82,517,000. Sycomore Asset Management grew its stake in shares of Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after buying an additional 4,079 shares during the last quarter. China Universal Asset Management Co. Ltd. boosted its holdings in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after acquiring an additional 525 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in Intuitive Surgical by 73.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider's stock worth $132,657,000 after purchasing an additional 114,149 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares of the company's stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company's stock, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,313 shares of company stock valued at $17,229,143 in the last 90 days. Company insiders own 0.70% of the company's stock.

Analyst Ratings Changes

Several analysts have commented on the company. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday, January 24th. Royal Bank of Canada lowered their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Bernstein Bank increased their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. Robert W. Baird decreased their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Trading Down 0.0 %

Shares of ISRG stock traded down $0.23 during trading hours on Friday, reaching $537.93. 546,369 shares of the company's stock were exchanged, compared to its average volume of 1,624,149. Intuitive Surgical, Inc. has a 1 year low of $379.67 and a 1 year high of $616.00. The stock has a market cap of $192.80 billion, a PE ratio of 83.92, a PEG ratio of 5.85 and a beta of 1.70. The stock's fifty day moving average price is $501.36 and its two-hundred day moving average price is $534.58.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the prior year, the firm posted $1.50 earnings per share. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.